Cleveland.com: Ventilator shortage during coronavirus? 3-D printing could save lives

UC anesthesiologist discusses ventilators

Imagine printing a three-dimensional piece of plastic that could help save a coronavirus patient’s life. 3-D printing is one solution proposed to address an expected shortage of ventilators, machines that keep patients whose lungs are severely damaged alive.  Experts are expecting a shortages of ventilators as the number of people impacted by the coronavirus pandemic grows in the U.S.

Ventilators work through a breathing tube inserted into a person’s windpipe. The machine inflates the lungs with air and then deflates the lungs, removing carbon dioxide. A medical professional uses a computer to control the amount of pressure placed on the lungs and the amount of oxygen.

Coronavirus patients are at risk of pneumonia and acute respiratory distress syndrome, which has a high mortality rate. Dr. Suzanne Bennett, an associate professor at the UC College of Medicine and an anesthesiologist at UC Health, discussed the workings of ventilators.

A traditional ventilator costs about $25,000 to $50,000. Bennett said some of the “bells and whistles" on a hospital-grade ventilator help medical professionals operate the machine effectively, and reduce the workload for respiratory therapists. With a shortage, respiratory therapists would be spread thin.

“I think all of us are concerned with the safety of that patient in that situation,” she said.

Read the interview with Dr. Bennett.

Related Stories

1

Breakthrough skin science discovery

March 12, 2026

A research collaboration between the University of Cincinnati and global cosmetics company Kose led to the creation of a novel anti aging spot fading serum.

2

Study: Additional radiation for liver cancer does not increase toxicity

March 10, 2026

New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.